蜂蜜假药在治疗儿科功能性便秘方面的有效性:一项比较研究
Guili Yu1, Jing Gao1, Jinglian Gu1
1Department of traditional Chinese medicine, Pujiang Community Health Service Center, Shanghai, China.
Journal of paediatrics and child health
|November 15, 2024
概括
蜂蜜假药有效地治疗学龄前儿童的功能性便秘. 与标准护理相比,这种自然疗法显示出肠道排便和症状得分的显著改善.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 传统中国医药 传统中国医药
- 自然产品治疗药物 自然产品治疗药物
背景情况:
- 功能性便秘是一种常见的儿科问题.
- 考虑了传统中医 (TCM) 的原则,如阴缺乏和肠干燥.
- 现有的治疗方法可能有局限性,需要探索替代方案.
研究的目的:
- 评估蜂蜜假药在学龄前儿童功能性便秘的临床有效性.
- 为了比较蜂蜜支架与儿童便秘的标准护理.
- 根据TCM原则评估安全性和有效性.
主要方法:
- 进行了一项随机对照试验 (RCT).
- 参与者是被诊断患有功能性便秘的学前儿童.
- 治疗组与标准护理一起接受蜂蜜;对照组仅接受标准护理.
主要成果:
- 蜂蜜剂组的便秘得分显著降低,肠道排便频率增加 (P<0.05).
- 在治疗组中观察到更高的完全康复率和整体有效性 (P<0.05).
- 基线特征在各组之间是可比的,确保可靠的结果.
结论:
- 蜂蜜支架代表了对儿科功能性便秘的有前途的干预措施.
- 与标准护理相比,治疗显示出显著的临床益处.
- 蜂蜜支柱可以提供一个更安全,更有效的替代方案来管理儿童便秘.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
136
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
136
Drugs Affecting GI Tract Motility: Other Laxatives
170
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
170
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
186
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
186
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
176
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
176
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
212
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
212


